-
PurposeThis is an envelope gene encoding plasmid to make retrogradely lentiviral vector. You can make type B2 envelope coating virus particle with HiRet by using this plasmid.
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 67513 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepCAGGS vector
- Backbone size w/o insert (bp) 4900
- Total vector size (bp) 6421
-
Vector typeLentiviral
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)Stbl3
-
Growth instructionsDH5alpha is also a suitable growth strain.
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameFusion Glycoprotein type B2
-
Alt nameFuG-B2
-
SpeciesG. gallus (chicken), B. taurus (bovine); Vesicular stomatitis Indiana virus, Rabies virus, Cytomegalovirus, Simian virus 40, Oryctolagus cuniculus
-
Insert Size (bp)1530
- Promoter CAGGS
-
Tag
/ Fusion Protein
- Fusion protein of Vesicular stomatitis Indiana virus and Rabies virus (C terminal on backbone)
Cloning Information
- Cloning method Unknown
- 5′ sequencing primer Unknown
- 3′ sequencing primer Unknown (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
-
A portion of this plasmid was derived from a plasmid made byFusion glycoproteins are composed of parts of rabies virus glycoprotein (RV-G) and vesicular stomatitis virus glycoprotein (VSV-G). In three glycoproteins including FuG-B, FuG-C, and FuG-E, the sequences of RV-G are derived from the challenged virus standard (CVS) strain of rabies virus, whereas those in FuG-B2 are from Pasteur virus (PV) strain of the virus. The CVS RV-G cDNA was provided by Dr. K. Morimoto at Yasuda Women’s University (Hiroshima, Japan) (ref: MORIMOTO, K., HOOPER, D.C., CARBAUGH, H., FU, Z.F., KOPROWSKI, H., and DIETZSCHOLD, B. Rabies virus quasispecies: implications for pathogenesis. Proc. Natl. Acad. Sci. USA 95, 3152-3156, 1998), and the PV RV-G cDNA was chemically synthesized on the basis of the GenBank data (accession number: GU992322). The VSV-G cDNA was provided by Dr. A. Nienhuis at St. Jude Children’s Research Hospital.
-
Article Citing this Plasmid
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pCAGGS-FuG-B2 was a gift from Kazuto Kobayashi (Addgene plasmid # 67513 ; http://n2t.net/addgene:67513 ; RRID:Addgene_67513) -
For your References section:
Selective neural pathway targeting reveals key roles of thalamostriatal projection in the control of visual discrimination. Kato S, Kuramochi M, Kobayashi K, Fukabori R, Okada K, Uchigashima M, Watanabe M, Tsutsui Y, Kobayashi K. J Neurosci. 2011 Nov 23;31(47):17169-79. doi: 10.1523/JNEUROSCI.4005-11.2011. 10.1523/JNEUROSCI.4005-11.2011 PubMed 22114284